Provenienza dei contatti di primo grado di Brian R. MacDonald
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA.
9
| Holding Company | Pharmaceuticals: Major | 9 |
| Public Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Brian R. MacDonald tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Major Banks | Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| LIPOSCIENCE INC | Medical Specialties | Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Chairman | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Public Communications Contact | |
| RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Director/Board Member | |
DC Brau Brewing LLC
 DC Brau Brewing LLC Beverages: AlcoholicConsumer Non-Durables DC Brau Brewing LLC manufactures and distributes beer. The company was founded by Jeffrey Hancock and Brandon Skall in 2009 and is headquartered in Washington, DC. | Beverages: Alcoholic | Director/Board Member | |
Hapten Sciences, Inc.
 Hapten Sciences, Inc. Pharmaceuticals: MajorHealth Technology Hapten Sciences, Inc. is a biopharmaceutical company. It identifies and develops novel, early-stage products that contribute to the health and well being of people around the world. Its product include PDC-APB, a small molecule that acts like a vaccine to prevent the extremely painful itching and rash. The company was founded by Raymond Joseph Hage Jr. and is headquartered in Memphis, TN. | Pharmaceuticals: Major | Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Gliacure, Inc.
 Gliacure, Inc. BiotechnologyHealth Technology Gliacure, Inc. is engaged in the development of novel therapies for neurological and neuropsychiatric disorders based on glia targets. The company was founded by Philip Haydon in 2011 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Drugstore Chains | Director/Board Member | |
| University of Pennsylvania | College/University | Masters Business Admin Director/Board Member Doctorate Degree | |
| Vanderbilt University | College/University | Undergraduate Degree Chief Tech/Sci/R&D Officer | |
| Drexel University | College/University | Graduate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Deloitte Consulting LLP
 Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LLP provides business consulting services. It offers services related to public finance, public sector management, health and social protection, information technology, financial sector, and trade and investment. The company was founded in 1996 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Amarin Pharmaceuticals, Inc.
 Amarin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Amarin Pharmaceuticals, Inc. is a pharmaceutical company that manufactures and develops pharmaceuticals. The company is based in Mill Valley, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| Indiana University | College/University | Masters Business Admin Masters Business Admin | |
Prospect Venture Partners
 Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Founder | |
| INSULET CORPORATION | Medical Specialties | Director/Board Member | |
| Georgetown University | College/University | Undergraduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Chairman | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
| Licensing Executives Society | Director/Board Member | ||
Booz Allen Hamilton International (U.K.) Ltd.
 Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Locust Walk Partners LLC
 Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Founder Founder | |
I-Corp, Inc.
 I-Corp, Inc. Industrial MachineryProducer Manufacturing I-Corp, Inc. is an American company that specializes in cutting, milling, and fabricating machine parts. | Industrial Machinery | Director/Board Member | |
| Goizueta Business School-Emory | College/University | Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
UTILITY therapeutics Ltd.
 UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Chairman | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Founder | |
| CYTEIR THERAPEUTICS, INC. | Biotechnology | Chairman |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Regno Unito | 3 |
| Irlanda | 2 |
| Francia | 2 |
| Israele | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 5 |
| Producer Manufacturing | 3 |
Posizioni
| Director/Board Member | 85 |
| Corporate Officer/Principal | 44 |
| Chairman | 35 |
| Independent Dir/Board Member | 24 |
| Chief Executive Officer | 14 |
Contatti più connessi
| Insiders | |
|---|---|
| Joseph Zakrzewski | 30 |
| Donald Hayden | 23 |
| Paul J. Schmitt | 22 |
| Alan Roemer | 21 |
| Alexander E. Barkas | 19 |
| Joan Lau | 19 |
| Jaisim Shah | 17 |
| Jan van Heek | 15 |
| George McLendon | 12 |
| Jay Mohr | 10 |
| Joseph S. Mohr | 9 |
| Stephen M. Condon | 6 |
- Borsa valori
- Insiders
- Brian R. MacDonald
- Connessioni Società
